Free morning briefing · 07:30 weekdays
The RNS that moves prices, in your inbox before the open.
AI-ranked movers and high-impact RNS across the FTSE 100, 250, SmallCap and AIM — one short email, every market day.
Get the briefing
PRTC

PureTech Health plc

PRTCLSEUnited StatesHealthcareBiotechnologyFTSE SmallCap

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. It is developing LYT-100, a Phase 3-ready therapeutic candidate with the potential to establish a new standard of care (SOC) for the treatment of idiopathic…more

P/B1.24xROIC-33.0%
£292.10M
Market Cap
EV: £200.24M
MOM3
QUAL3
VAL3
RSK4
PRTC
£292.10M
Market Cap · EV £200.24M

PureTech Health plc

MOM3
QUAL3
VAL3
RSK4

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. It is developing LYT-100, a Phase 3-ready therapeutic candidate with the potential to establish a new standard of care (SOC) for the treatment of idiopathic…more

Latest RNS from PureTech Health plc

Analyst consensus: Buy

As of 22 Jul 2026, 3 analysts rate PureTech Health plc a Buy, with 100% buy ratings and a mean price target of 363p (range 233p–504p), +188% vs the current price.

Strong buy: 0Buy: 3Hold: 0Sell: 0Strong sell: 0

Full analyst history →

More Healthcare companies